Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does EPOPROSTENOL Cause Haemodynamic instability? 37 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 37 reports of Haemodynamic instability have been filed in association with EPOPROSTENOL (EPOPROSTENOL). This represents 0.3% of all adverse event reports for EPOPROSTENOL.

37
Reports of Haemodynamic instability with EPOPROSTENOL
0.3%
of all EPOPROSTENOL reports
17
Deaths
27
Hospitalizations

How Dangerous Is Haemodynamic instability From EPOPROSTENOL?

Of the 37 reports, 17 (45.9%) resulted in death, 27 (73.0%) required hospitalization, and 4 (10.8%) were considered life-threatening.

Is Haemodynamic instability Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for EPOPROSTENOL. However, 37 reports have been filed with the FAERS database.

What Other Side Effects Does EPOPROSTENOL Cause?

Dyspnoea (2,744) Headache (2,425) Diarrhoea (2,310) Nausea (2,016) Pain in jaw (1,928) Death (1,362) Flushing (1,256) Fatigue (1,133) Hospitalisation (1,078) Vomiting (1,068)

What Other Drugs Cause Haemodynamic instability?

METFORMIN (371) AMLODIPINE (335) TACROLIMUS (197) DEXAMETHASONE (185) ACETAMINOPHEN (184) PROPOFOL (182) VANCOMYCIN (171) PREDNISONE (156) MYCOPHENOLATE MOFETIL (142) METHYLPREDNISOLONE (137)

Which EPOPROSTENOL Alternatives Have Lower Haemodynamic instability Risk?

EPOPROSTENOL vs EPTIFIBATIDE EPOPROSTENOL vs EPTINEZUMAB-JJMR EPOPROSTENOL vs EPTINEZUMAB\EPTINEZUMAB-JJMR EPOPROSTENOL vs EQUINE BOTULINUM NEUROTOXIN A/B/C/D/E/F/G IMMUNE FAB2 EPOPROSTENOL vs EQUINE THYMOCYTE IMMUNE GLOBULIN

Related Pages

EPOPROSTENOL Full Profile All Haemodynamic instability Reports All Drugs Causing Haemodynamic instability EPOPROSTENOL Demographics